Immunohistochemical detection of nuclear survivin in NSCLC: A comparison of commercial antibodies [6]

Histopathology

Volumn 50, Issue 5, 2007, Pages 671-675

  Vischioni, B ^a   Oudejans, J J ^a   Kruyt, F A E ^a   Giaccone, G ^a   Rodriguez, J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SURVIVIN;

CORRELATION ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LETTER; LUNG NON SMALL CELL CANCER; MITOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; CELL NUCLEUS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33947617759     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02629.x     Document Type: Letter

References (10)

1. Altieri DC. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 2003; 3; 46-53.
2. Okada E, Murai Y, Matsui K et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 2001; 163; 109-116.
3. Grabowski P, Kühnel T, Mühr-Wilkenshoff F et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 2003; 88; 115-119.
4. Vischioni B, van der Valk P, Span SW, Kruyt FAE, Rodriguez JA, Giaccone G. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann. Oncol. 2004; 15; 1654-1660.
5. Lu B, Gonzalez A, Massion PP, Shyr Y, Carbone DP, Hallahan DE. Nuclear survivin as a biomarker for non-small-cell lung cancer. Br. J. Cancer 2004; 91; 537-540.
6. Shinohara ET, Gonzalez A, Massion PP et al. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 2005; 103; 1685-1692.
7. Fortugno P, Wall NR, Giodini A et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 2002; 115; 575-585.
8. Rodriguez JA, Span SW, Ferreira CG, Kruyt FAE, Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp. Cell Res. 2002; 275; 44-53.
9. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999; 59; 6097-6102.
10. Skoufias DA, Mollinari C, Lacroix FB, Margolis RL. Human survivin is kinetochore-associated passenger protein. J. Cell Biol. 2000; 151; 1575-1581.